semaglutide brain effects for Weight Loss FAQ's Weight Loss Drug Semaglutide as a Cornerstone Therapy

Use: For research and laboratory use only

We have 10 Phase 3 trials of our ultra-long acting GLP-1 RA candidate planned to start this year, with 20+ studies planned across our overall obesity portfolio

Explore the intersection of GLP-1 therapies and gut health to manage metabolic dysfunction and support patient wellness.

Ania Jastreboff at #ADA2026 TRIUMPH-1: Phase 3 Obesity Trial with Retatrutide Retatrutide , a once-weekly triple hormone receptor agonist

In this Review, the authors discuss neuromodulation therapies in relation to current knowledge of the nerve circuitry, provide insights into possible mechanisms and explore reasons for limited success and how effectiveness might be improved.